FR2345146A1 - Nouveau medicament a base d'(hydroxy-2 indanyl-2) 1-propanol - Google Patents

Nouveau medicament a base d'(hydroxy-2 indanyl-2) 1-propanol

Info

Publication number
FR2345146A1
FR2345146A1 FR7608321A FR7608321A FR2345146A1 FR 2345146 A1 FR2345146 A1 FR 2345146A1 FR 7608321 A FR7608321 A FR 7608321A FR 7608321 A FR7608321 A FR 7608321A FR 2345146 A1 FR2345146 A1 FR 2345146A1
Authority
FR
France
Prior art keywords
anorexigenic
indanyl
propanol
hydroxy
contg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7608321A
Other languages
English (en)
French (fr)
Other versions
FR2345146B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Jacques Logeais SA
Original Assignee
Laboratoires Jacques Logeais SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Jacques Logeais SA filed Critical Laboratoires Jacques Logeais SA
Priority to FR7608321A priority Critical patent/FR2345146A1/fr
Publication of FR2345146A1 publication Critical patent/FR2345146A1/fr
Application granted granted Critical
Publication of FR2345146B1 publication Critical patent/FR2345146B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7608321A 1976-03-23 1976-03-23 Nouveau medicament a base d'(hydroxy-2 indanyl-2) 1-propanol Granted FR2345146A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7608321A FR2345146A1 (fr) 1976-03-23 1976-03-23 Nouveau medicament a base d'(hydroxy-2 indanyl-2) 1-propanol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7608321A FR2345146A1 (fr) 1976-03-23 1976-03-23 Nouveau medicament a base d'(hydroxy-2 indanyl-2) 1-propanol

Publications (2)

Publication Number Publication Date
FR2345146A1 true FR2345146A1 (fr) 1977-10-21
FR2345146B1 FR2345146B1 (enExample) 1979-10-05

Family

ID=9170778

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7608321A Granted FR2345146A1 (fr) 1976-03-23 1976-03-23 Nouveau medicament a base d'(hydroxy-2 indanyl-2) 1-propanol

Country Status (1)

Country Link
FR (1) FR2345146A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020255A1 (de) * 2001-08-31 2003-03-13 Aventis Pharma Deutschland Gmbh Verwendung von mehrfach substituierten indan-1-ol-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
WO2003020263A1 (de) * 2001-08-31 2003-03-13 Aventis Pharma Deutschland Gmbh Verwendung von c2-substituierten indan-1-ol-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020255A1 (de) * 2001-08-31 2003-03-13 Aventis Pharma Deutschland Gmbh Verwendung von mehrfach substituierten indan-1-ol-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
WO2003020263A1 (de) * 2001-08-31 2003-03-13 Aventis Pharma Deutschland Gmbh Verwendung von c2-substituierten indan-1-ol-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
US7763662B2 (en) 2001-08-31 2010-07-27 Sanofi-Aventis Deutschland Gmbh Use of C2-substituted indan-1-ol systems for preparing medicaments for the prophylaxis or treatment of obesity

Also Published As

Publication number Publication date
FR2345146B1 (enExample) 1979-10-05

Similar Documents

Publication Publication Date Title
DE3374300D1 (en) Stabilized activated oxygen and medicaments containing this stabilized activated oxygen
EP0244080A3 (en) Medicament for the treatment of obesity
ES441814A1 (es) Dispositivo anticonceptivo mediante anillo vaginal.
HUT45197A (en) Process for producing implantable drug-storing preparations
FR2558373B1 (fr) Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
AU557701B2 (en) Imizalil and hexamidine diisothionate acne solution
BG97678A (en) Beta -carotene and/or vitamin e therapy for inhibition of major vascular events
ATE109351T1 (de) Therapeutisches erzeugnis zur behandlung von beschwerden während der oder nach den wechseljahren.
YU48559B (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
MY103741A (en) Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process
IL81573A (en) Pharmaceutical preparations for the treatment of psoriasis containing tamoxifen
JPS5234935A (en) Medicinal composition
IE42950L (en) X-ray contrast preparations
JPS5218813A (en) Plasters for the relief of cutaneous diseases
FR2345146A1 (fr) Nouveau medicament a base d'(hydroxy-2 indanyl-2) 1-propanol
ZA877901B (en) Active compounds for use in the treatment of tumors
EP0290262A3 (en) Improved nitrate therapy for angina pectoris
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
MY102991A (en) Medicaments for treating hypertension.
UA19674A (uk) Композиція для обробки коhтактhих ліhз
NZ183842A (en) Immunological oral medicament for treatment and preventionof gastroenteritis, partucularly infantile gastroenteritis
FR2244481A1 (en) Oral treatment of diabetes - with a complex of glibenclamide and phenformin
AU555496B2 (en) Phenoxypyridine ffor normalizing hippocampal function

Legal Events

Date Code Title Description
ST Notification of lapse